Wiroj Mankhatitham

Summary

Publications

  1. ncbi Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy
    Wiroj Mankhatitham
    Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
    J Med Assoc Thai 95:163-9. 2012
  2. ncbi Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen
    Wiroj Mankhatitham
    Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
    Southeast Asian J Trop Med Public Health 42:651-8. 2011
  3. doi Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting
    Krittaecho Siripassorn
    Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
    AIDS Res Hum Retroviruses 26:139-48. 2010

Collaborators

Detail Information

Publications3

  1. ncbi Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy
    Wiroj Mankhatitham
    Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
    J Med Assoc Thai 95:163-9. 2012
    ..To study and compare the pattern of lipid profile changes in Thai HIV and tuberculosis (TB) co-infected patients after receiving two non-nucleoside reverse transcriptase inhibitors (NNRTIs)-based antiretroviral therapy (ART)...
  2. ncbi Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen
    Wiroj Mankhatitham
    Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
    Southeast Asian J Trop Med Public Health 42:651-8. 2011
    ..03; 95%CI 1.26-7.29) was an independent risk factor associated with grade 1-4 hepatotoxicity (p=0.013). Monitoring of hepatotoxicity should be considered in TB/HIV-1 co-infected patients who are infected with HCV and receiving NVP...
  3. doi Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting
    Krittaecho Siripassorn
    Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
    AIDS Res Hum Retroviruses 26:139-48. 2010
    ..In the subgroup analysis, patients who received double-boosted PIs demonstrated a superior immunological response but not better virological outcomes compared to the single-boosted PI +/- OBR group...